XTL Biopharmaceuticals Ltd: Form 6-K, filed May 13, 2024
Filed with the SEC on May 13, 2024 and accepted by EDGAR at May 13, 2024, 14:32 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001213900-24-042015. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.